Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IBS
Pharma
J&J's Stelara fails to top Humira in head-to-head Crohn's study
Stelara didn't prove superior to Humira in a Crohn's head-to-head—at least not efficacy-wise—but J&J figures the safety stats offer an edge.
Fraiser Kansteiner
May 23, 2021 4:14pm
Salix shines a light on IBS patients' pandemic suffering
Apr 28, 2021 10:10am
AZ takes full China rights to Ironwood's IBS-C star Linzess
Sep 18, 2019 10:40am
Can Zelnorm compete in IBS-C a decade after recall?
Sep 17, 2019 6:50pm
Sandoz SXSW hackathon names 3 winners
Mar 13, 2019 9:33am
Cosmo wins FDA green light to challenge Bausch's Xifaxan
Nov 20, 2018 11:43am
